Stomach/Duodenum News

LAS VEGAS — A national destination care program for bariatric surgery can be both safe and effective, with an analysis suggesting the model is associated with higher satisfaction metrics and similar 30-day clinical outcomes for complications and readmissions when compared with non-destination care programs, according to findings presented at ObesityWeek.

LAS VEGAS — Adults with overweight or obesity who received a swallowable gastric balloon that deflates on its own experienced a significant decrease in body weight and cardiometabolic disease markers with few adverse events, according to findings presented at ObesityWeek.

SAN ANTONIO — A novel therapeutic agent helped reduce eosinophil counts and improve symptoms in patients with eosinophilic gastritis and eosinophilic gastroenteritis, according to study results presented at the American College of Gastroenterology Annual Meeting.

SAN ANTONIO — Starting this weekend, Healio Gastroenterology and Liver Disease will provide live coverage as the exclusive media partner of the American College of Gastroenterology’s 84th Annual Scientific Meeting.

Regardless of the surgery type, the risk of postoperative pulmonary embolism was elevated at more than 6 weeks postoperatively, according to published results.

SAN ANTONIO — Healio will host its second Disruptive Innovators reception during the American College of Gastroenterology’s Annual Scientific Meeting (ACG 2019) on October 27, 2019, at the Grand Hyatt San Antonio.

Healio Gastroenterology and Liver Disease has compiled a list of some of the most recent approvals and updates from the FDA.

Healthy adults who take broad-spectrum antibiotics may impair their body’s immune response to influenza vaccination, according to findings from a small study published in Cell.

Over the course of 22 years of follow-up, treatment for Helicobacter pylori infection, as well as vitamin and garlic supplementation, reduced the risk for death due to gastric cancer.

Analyzing bacteria in the gut, researchers have determined that patients presenting with hypertension plus depression may have an entirely different disease than those with hypertension alone, according to preliminary research presented at the American Heart Association’s 2019 Hypertension Scientific Sessions.